Yang Shen

Person

Scarsdale, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibodies targeting immune checkpoints
- Patent number 11,939,381
- Issue date Mar 26, 2024
- Eli Lilly and Company
- Stephen J. Demarest
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1-anti-TIM-3 bispecific antibodies
- Patent number 11,351,251
- Issue date Jun 7, 2022
- Eli Lilly and Company
- Yiwen Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Checkpoint inhibitor bispecific antibodies
- Patent number 11,203,640
- Issue date Dec 21, 2021
- Eli Lilly and Company
- Michael Dewain Kalos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1-anti-TIM-3 bispecific antibodies
- Patent number 10,279,034
- Issue date May 7, 2019
- Eli Lilly and Company
- Yiwen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-Tim-3 antibodies
- Patent number 10,253,096
- Issue date Apr 9, 2019
- Eli Lilly and Company
- Yi Zhang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CIRCULARIZED ANTIBODY MOLECULES
- Publication number 20250011449
- Publication date Jan 9, 2025
- Regeneron Pharmaceuticals, Inc.
- Tri NGUYEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20240425609
- Publication date Dec 26, 2024
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20240400687
- Publication date Dec 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF
- Publication number 20240309072
- Publication date Sep 19, 2024
- Regeneron Pharmaceuticals, Inc.
- Nianshuang WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOF
- Publication number 20240307512
- Publication date Sep 19, 2024
- Regeneron Pharmaceuticals, Inc.
- Nianshuang WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF
- Publication number 20240287162
- Publication date Aug 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Nianshuang WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACE2 FUSION PROTEINS AND USES THEREOF
- Publication number 20240252601
- Publication date Aug 1, 2024
- Regeneron Pharmaceuticals, Inc.
- Nianshuang WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20240247069
- Publication date Jul 25, 2024
- Regeneron Pharmaceuticals, Inc.
- Yan YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...
- Publication number 20230416396
- Publication date Dec 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20230279153
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC FGF21 RECEPTOR AGONISTS AND THEIR USES
- Publication number 20220372168
- Publication date Nov 24, 2022
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES
- Publication number 20220251220
- Publication date Aug 11, 2022
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES TARGETING IMMUNE CHECKPOINTS
- Publication number 20210292416
- Publication date Sep 23, 2021
- Eli Lilly and Company
- Stephen J. DEMAREST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES
- Publication number 20210130477
- Publication date May 6, 2021
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES
- Publication number 20190247497
- Publication date Aug 15, 2019
- Eli Lilly and Company
- Yiwen LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Checkpoint Inhibitor Bispecific Antibodies
- Publication number 20190010232
- Publication date Jan 10, 2019
- Eli Lilly and Company
- Michael Dewain Kalos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES
- Publication number 20180289803
- Publication date Oct 11, 2018
- Eli Lilly and Company
- Yiwen LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TIM-3 ANTIBODIES
- Publication number 20180057591
- Publication date Mar 1, 2018
- Eli Lilly and Company
- Yi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bispecific antibodies targeting immune checkpoints

Anti-PD-L1-anti-TIM-3 bispecific antibodies

Checkpoint inhibitor bispecific antibodies

Anti-PD-L1-anti-TIM-3 bispecific antibodies

Anti-Tim-3 antibodies

Patents Applicationslast 30 patents

CIRCULARIZED ANTIBODY MOLECULES

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF

ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOF

MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF

ACE2 FUSION PROTEINS AND USES THEREOF

FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF

MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

MULTISPECIFIC FGF21 RECEPTOR AGONISTS AND THEIR USES

N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES

BISPECIFIC ANTIBODIES TARGETING IMMUNE CHECKPOINTS

N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES

ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES

Checkpoint Inhibitor Bispecific Antibodies

ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES

ANTI-TIM-3 ANTIBODIES